OrbiMed Advisors as of June 30, 2011
Portfolio Holdings for OrbiMed Advisors
OrbiMed Advisors holds 100 positions in its portfolio as reported in the June 2011 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 4.5 | $143M | 3.5M | 41.41 | |
Bristol Myers Squibb (BMY) | 4.5 | $142M | 4.9M | 28.96 | |
WellPoint | 4.5 | $142M | 1.8M | 78.77 | |
Pfizer (PFE) | 4.4 | $139M | 6.7M | 20.60 | |
Allergan | 4.0 | $127M | 1.5M | 83.25 | |
Shire | 2.8 | $90M | 955k | 94.21 | |
UnitedHealth (UNH) | 2.5 | $79M | 1.5M | 51.58 | |
Merck & Co (MRK) | 2.4 | $77M | 2.2M | 35.29 | |
Warner Chilcott Plc - | 2.4 | $76M | 3.1M | 24.13 | |
BioMarin Pharmaceutical (BMRN) | 2.3 | $72M | 2.6M | 27.21 | |
Johnson & Johnson (JNJ) | 2.3 | $72M | 1.1M | 66.52 | |
Express Scripts | 2.2 | $71M | 1.3M | 53.98 | |
Thermo Fisher Scientific (TMO) | 2.2 | $70M | 1.1M | 64.39 | |
Pharmasset | 2.1 | $68M | 607k | 112.20 | |
Incyte Corporation (INCY) | 2.1 | $67M | 3.5M | 18.94 | |
Watson Pharmaceuticals | 2.0 | $64M | 927k | 68.73 | |
Complete Genomics | 2.0 | $64M | 4.2M | 15.28 | |
Illumina (ILMN) | 1.9 | $61M | 810k | 75.15 | |
Pharmacyclics | 1.9 | $60M | 5.8M | 10.44 | |
Life Technologies | 1.8 | $58M | 1.1M | 52.07 | |
NxStage Medical | 1.8 | $57M | 2.7M | 20.82 | |
Medtronic | 1.7 | $55M | 1.4M | 38.53 | |
Humana (HUM) | 1.7 | $55M | 680k | 80.54 | |
CIGNA Corporation | 1.6 | $51M | 998k | 51.43 | |
Elan Corporation | 1.6 | $51M | 4.5M | 11.37 | |
Human Genome Sciences | 1.6 | $49M | 2.0M | 24.54 | |
Zimmer Holdings (ZBH) | 1.2 | $38M | 595k | 63.20 | |
NPS Pharmaceuticals | 1.2 | $38M | 4.0M | 9.45 | |
Mylan | 1.1 | $36M | 1.5M | 24.67 | |
Affymetrix | 1.1 | $35M | 4.4M | 7.93 | |
Sequenom | 1.1 | $35M | 4.6M | 7.55 | |
Perrigo Company | 1.1 | $35M | 396k | 87.87 | |
Baxter International (BAX) | 1.1 | $34M | 568k | 59.69 | |
Pacira Pharmaceuticals (PCRX) | 1.1 | $34M | 2.8M | 12.00 | |
Insulet Corporation (PODD) | 1.0 | $32M | 1.5M | 22.17 | |
Hospira | 0.9 | $29M | 510k | 56.66 | |
Aetna | 0.9 | $29M | 648k | 44.09 | |
3SBio (SSRX) | 0.9 | $28M | 1.6M | 17.43 | |
EXACT Sciences Corporation (EXAS) | 0.9 | $27M | 3.1M | 8.60 | |
Vivus | 0.8 | $26M | 3.2M | 8.14 | |
Amarin Corporation (AMRN) | 0.8 | $26M | 1.8M | 14.43 | |
McKesson Corporation (MCK) | 0.8 | $26M | 308k | 83.65 | |
MAP Pharmaceuticals | 0.8 | $25M | 1.6M | 15.97 | |
Anthera Pharmaceuticals | 0.8 | $25M | 3.0M | 8.17 | |
Align Technology (ALGN) | 0.8 | $24M | 1.0M | 22.80 | |
Stryker Corporation (SYK) | 0.7 | $24M | 401k | 58.69 | |
Forest Laboratories | 0.7 | $23M | 578k | 39.34 | |
Celgene Corporation | 0.7 | $22M | 358k | 60.32 | |
Allos Therapeutics | 0.7 | $21M | 9.7M | 2.14 | |
Valeant Pharmaceuticals Int | 0.7 | $21M | 398k | 51.96 | |
Cardinal Health (CAH) | 0.6 | $20M | 437k | 45.42 | |
Biogen Idec (BIIB) | 0.6 | $20M | 186k | 106.92 | |
Antares Pharma | 0.6 | $20M | 9.0M | 2.21 | |
Hca Holdings (HCA) | 0.6 | $20M | 596k | 33.00 | |
Given Imaging | 0.6 | $18M | 905k | 20.35 | |
OraSure Technologies (OSUR) | 0.6 | $19M | 2.2M | 8.53 | |
Incyte Corp note 4.750%10/0 | 0.6 | $18M | 7.7M | 2.30 | |
Affymax (AFFY) | 0.6 | $18M | 2.5M | 6.87 | |
K-V Pharmaceutical Company | 0.6 | $17M | 6.4M | 2.72 | |
Medivation | 0.5 | $15M | 713k | 21.43 | |
Idenix Pharmaceuticals | 0.4 | $14M | 2.7M | 5.00 | |
Oncothyreon | 0.4 | $13M | 1.4M | 9.19 | |
CareFusion Corporation | 0.4 | $12M | 434k | 27.17 | |
ArQule | 0.4 | $12M | 1.9M | 6.25 | |
Inhibitex | 0.3 | $11M | 2.8M | 3.92 | |
D Fluidigm Corp Del (LAB) | 0.3 | $11M | 649k | 16.77 | |
Onyx Pharmaceuticals | 0.3 | $9.9M | 280k | 35.30 | |
Volcano Corporation | 0.3 | $8.4M | 260k | 32.29 | |
Boston Scientific Corporation (BSX) | 0.3 | $8.3M | 1.2M | 6.91 | |
Agilent Technologies Inc C ommon (A) | 0.2 | $8.0M | 157k | 51.11 | |
Alexion Pharmaceuticals | 0.2 | $8.1M | 171k | 47.03 | |
InterMune | 0.2 | $7.2M | 201k | 35.85 | |
Targacept | 0.2 | $7.2M | 342k | 21.07 | |
Covidien | 0.2 | $6.9M | 130k | 53.23 | |
DaVita (DVA) | 0.2 | $5.6M | 65k | 86.62 | |
Cubist Pharmaceuticals | 0.2 | $5.8M | 163k | 35.98 | |
Biodel | 0.2 | $5.6M | 3.0M | 1.87 | |
Uroplasty | 0.2 | $5.4M | 725k | 7.50 | |
Anadys Pharmaceuticals (ANDS) | 0.2 | $5.4M | 5.3M | 1.02 | |
Hologic (HOLX) | 0.2 | $5.0M | 250k | 20.17 | |
Regeneron Pharmaceuticals (REGN) | 0.1 | $4.4M | 77k | 56.71 | |
Edwards Lifesciences (EW) | 0.1 | $4.4M | 50k | 87.18 | |
Amgen (AMGN) | 0.1 | $4.3M | 74k | 58.34 | |
Syneron Medical Ltd ord | 0.1 | $4.4M | 364k | 12.13 | |
Quest Diagnostics Incorporated (DGX) | 0.1 | $4.3M | 73k | 59.10 | |
Athersys | 0.1 | $4.4M | 1.6M | 2.71 | |
Medco Health Solutions | 0.1 | $4.1M | 73k | 56.52 | |
Insmed (INSM) | 0.1 | $4.1M | 341k | 11.99 | |
Sanofi Aventis Wi Conval Rt | 0.1 | $3.8M | 1.6M | 2.41 | |
United Therapeutics Corporation (UTHR) | 0.1 | $3.5M | 63k | 55.10 | |
Trius Therapeutics | 0.1 | $3.6M | 450k | 7.92 | |
Pacific Biosciences of California (PACB) | 0.1 | $3.3M | 282k | 11.70 | |
Covance | 0.1 | $2.9M | 48k | 59.38 | |
CUBIST PHARM CONVERTIBLE security | 0.1 | $2.8M | 2.0M | 1.40 | |
D Tranzyme | 0.1 | $2.9M | 700k | 4.18 | |
Questcor Pharmaceuticals | 0.1 | $2.4M | 100k | 24.10 | |
Cynosure | 0.1 | $2.2M | 180k | 12.10 | |
Volcano Corporation note 2.875% 9/0 | 0.1 | $1.9M | 1.5M | 1.24 | |
Solta Medical | 0.0 | $1.4M | 493k | 2.76 | |
Orexigen Therapeutics | 0.0 | $318k | 200k | 1.59 |